Assessing Cognitive Therapy Instead Of Neuroleptics: Rationale, study design and sample characteristics of the ACTION trial
- 6 February 2013
- journal article
- research article
- Published by Taylor & Francis in Psychosis
- Vol. 5 (1) , 82-92
Abstract
Aims: Recent evidence regarding over-estimation of the efficacy of antipsychotics and under-estimation of their toxicity, as well as emerging data regarding alternative treatment options, suggest it may be time to introduce patient choice. However, only a small number of studies have reported on the efficacy of interventions for psychological interventions such as cognitive therapy. Early results suggest that cognitive therapy may be an effective, well-tolerated treatment for people who choose not to take antipsychotics. We report on the rationale and design for a multi-site randomised, controlled trial of cognitive therapy for people with a schizophrenia spectrum diagnosis who choose not to take antipsychotics. Methods: The study employs a single-blind design in which all participants receive treatment as usual, and half are randomised to up to 30 sessions of cognitive therapy for up to 9 months. Participants will be followed-up for a minimum of 9 months and to a maximum of 18 months. Results: We report the characteristics of the final sample at baseline (N = 74). Conclusions: Our study aims to expand the currently limited evidence base for best practice in interventions for individuals with psychosis who choose not to take antipsychotics.Keywords
This publication has 33 references indexed in Scilit:
- Long-term Antipsychotic Treatment and Brain VolumesArchives of General Psychiatry, 2011
- Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuitsNature Neuroscience, 2010
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and AdolescentsJAMA, 2009
- Influence of antipsychotics on mortality in schizophrenia: Systematic reviewSchizophrenia Research, 2009
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological RigorSchizophrenia Bulletin, 2007
- Group cognitive-behavioural therapy for schizophreniaThe British Journal of Psychiatry, 2006
- Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapyPsychological Medicine, 2003
- Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioningActa Psychiatrica Scandinavica, 2000
- Development and validation of measures of social phobia scrutiny fear and social interaction anxiety11Editor’s note: This article was written before the development of some contemporary measures of social phobia, such as the Social Phobia and Anxiety Inventory (Turner et al., 1989). We have invited this article for publication because of the growing interest in the scales described therein. S.T.Behaviour Research and Therapy, 1998